Axsome Therapeutics Announces AXS-07 Phase 3 Migraine Trial Results Selected by the American Academy of Neurology Science Committee as Featured Presentation
17 sept. 2020 07h00 HE
|
Axsome Therapeutics, Inc.
Data from MOMENTUM Phase 3 trial to be presented at the 2020 AAN Science Highlights Platform NEW YORK, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a...
Cloudian Drives Object Storage Growth and Software Strength in First Half of Fiscal Year
01 sept. 2020 08h00 HE
|
Cloudian
SAN MATEO, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Cloudian® today announced it added over 50 new customers for the first half of 2020, expanding the company’s customer base to approximately 500...
Algolia Adds 1,000 New Customers in First Half of 2020, Rising to Search & Discovery Needs Amidst Unprecedented Digital Adoption
31 août 2020 13h16 HE
|
Algolia
SAN FRANCISCO, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Algolia, the leading Search and Discovery solution, closed the first half of 2020 with strong growth and momentum, driven by an increase in...
Rockset Gains Momentum as the Industry’s Leading Real-Time Database in the Cloud
30 janv. 2020 09h00 HE
|
Rockset
SAN MATEO, Calif., Jan. 30, 2020 (GLOBE NEWSWIRE) -- Rockset, the leading real-time database built for the cloud, today announced that the company is seeing massive new user growth, significant...
Axsome Therapeutics Announces AXS-07 Achieves Co-Primary and Key Secondary Endpoints in MOMENTUM Phase 3 Migraine Trial in Patients with History of Inadequate Response
30 déc. 2019 06h15 HE
|
Axsome Therapeutics, Inc.
Demonstrated statistical significance on regulatory co-primary endpoints of pain freedom (p<0.001) and freedom from most bothersome symptom (p=0.002) at 2 hours, compared to placebo Demonstrated...
TigerGraph Improves Its Graph Database-As-A-Service With Enhanced Performance And More Robustness
03 déc. 2019 09h00 HE
|
TigerGraph, Inc.
LAS VEGAS, Dec. 03, 2019 (GLOBE NEWSWIRE) -- AWS re: Invent -- TigerGraph, the only scalable graph database for the enterprise, today announced new functionality and performance for TigerGraph...
Axsome Therapeutics to Host Investor R&D Call with Key Opinion Leaders Focusing on AXS-07 and the Unmet Needs in the Acute Treatment of Migraine
21 nov. 2019 07h00 HE
|
Axsome Therapeutics, Inc.
Company to host conference call on Monday, November 25 at 9:00 AM Eastern NEW YORK, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage...
Sourcegraph Announces New GitLab Native Integration, Universal Code Search Engine, and Amazing Company Momentum
12 nov. 2019 09h00 HE
|
SourceGraph
SAN FRANCISCO, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Sourcegraph, the leader in universal code search, intelligence, and automation, today announced a new collaboration with GitLab, along with the...
Axsome Therapeutics to Report Third Quarter 2019 Financial Results on November 7, 2019
29 oct. 2019 07h00 HE
|
Axsome Therapeutics, Inc.
Axsome to host conference call and webcast on Thursday, November 7, 2019 at 8:00 AM Eastern Time NEW YORK, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a...
Axsome Therapeutics Announces Results of MINDSET Physician Survey Affirming Unmet Need and Favorable Profile of AXS-07 in the Acute Treatment of Migraine
28 oct. 2019 07h05 HE
|
Axsome Therapeutics, Inc.
Majority of physicians indicate improved efficacy is most significant unmet need in the acute treatment of migraine Majority of physicians would be more likely to prescribe AXS-07 over current and...